- Shareholders Ratify Both Proposals -
LAKE FOREST, Ill., May 13 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2008 Annual Meeting of Shareholders in Wilmington, Del. The agenda included votes on two proposals and a brief update on the company's progress and strategy.
"Our 2007 results point to the success of our strategies of investing
for growth, and improving operating margins and cash flow," said
Christopher B. Begley, chairman and chief executive officer, Hospira. "It's
through our disciplined focus on executing these strategies that Hospira
has become the growing, profitable company it is today and is positioned
for continued success going forward."
During the annual meeting, shareholders:
-- elected the following directors for three-year terms expiring in 2011:
Irving W. Bailey, II, Ronald A. Matricaria and
Jacque J. Sokolov, M.D.; and
-- ratified the appointment of Deloitte & Touche LLP as Hospira's auditors
A full description of the above matters was included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's Web site at http://www.hospirainvestor.com, as are Begley's remarks made at today's meeting.
Hospira, Inc. is a global specialty pharmaceutical and medication
delivery company dedicated to Advancing Wellness(TM). As the world leader
in specialty generic injectable pharmaceuticals, Hospira offers one of the
broadest portfolios of generic acute-care and oncology injectables, as well
as integrated infusion therapy and medication management solutions. Through
its products, Hospira helps improve the safety, cost and productivity of
patient care. The company is headquartered in Lake Forest, Ill., and has
more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 -- A Caution Concerning
Forward-Looking Statements This press release contains statements that may be construed as forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K and the subsequent Form 10-Q, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.
|SOURCE Hospira, Inc.|
Copyright©2008 PR Newswire.
All rights reserved